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Abstract This study examined dimensions of crying and
its relations with ocular dryness and mental well-being in
patients with Sjo¨gren’s syndrome, a systemic autoimmune
disease with dryness as primary symptom. Three-hundred
patients with Sjo¨gren’s syndrome completed questionnaires
on crying, dryness, and well-being. The crying question-
naire revealed four dimensions: ‘‘Cryability’’ (comprising
both crying sensibility and ability to cry), Somatic conse-
quences, Frustration, and Suppression. Compared to 100
demographically-matched control participants from the
general population, patients scored low on Cryability and
high on Somatic consequences and Frustration. The crying
dimensions generally showed significant but weak associ-
ations with ocular dryness and mental well-being in
patients. This is the first quantitative study indicating that
crying problems are more common in patients with Sjo¨g-
ren’s syndrome than in the general population. Perhaps,
patients who experience problems with crying could be
helped to rely on other ways of expressing emotions than
crying in tear-inducing situations.
Keywords Sjo¨gren’s syndrome  Crying  Emotions 
Ocular dryness
Introduction
When Henrik Sjo¨gren introduced Sjo¨gren’s syndrome in
1933, he described 19 patients with rheumatism, dryness of
the mouth, and problems with crying. Patients reported that
their eyes stayed dry during crying, although they knew for
sure that they were able to cry with tears before, and they
also experienced irritations in the eyes, which colored red
(Sjo¨gren, 1933). In the years thereafter, Sjo¨gren’s syn-
drome has been firmly established as a disease, but up to
now, only a few studies have addressed problems with
crying in this group (Kassan, 2001; Messmer, 2009; Van
Bijsterveld, Kruize, & Bleys, 2003), and to date no
research on crying has been conducted in patients with
Sjo¨gren’s syndrome.
Sjo¨gren’s syndrome is a systemic autoimmune disease
with a female preponderance, affecting about 0.5 % of the
adult population. Lymphocyte infiltration of exocrine
glands results in the hallmark symptoms dryness of the
eyes (keratoconjunctivitis sicca) and mouth (xerostomia;
Bowman, Ibrahim, Holmes, Hamburger, & Ainsworth,
2004; Fox, Tornwall, & Michelson, 1999; Fox, 2005;
Thomas, Hay, Hajeer, & Silman, 1998; Vitali et al., 2002).
Ocular dryness and reduced tear production may influence
the ability to produce emotional tears (Kassan, 2001;
Sjo¨gren, 1933). Crying has been defined as a secretomotor
phenomenon characterized by the shedding of tears from
the lacrimal apparatus, without any irritation of the ocular
structures, and often accompanied by alterations in the
muscles of facial expression, vocalizations, and in some
cases, sobbing, which is the convulsive inhaling and
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exhaling of air with spasms of the respiratory and truncal
muscle groups (Patel, 1993). Crying is considered to have
at least two functions. First, it is a distress signal, a pow-
erful emotional expression that elicits attention and support
from the social environment. Second, it has been attributed
arousal-reduction functions that facilitate psychological
and physiological recovery when being distressed (Bylsma,
Vingerhoets, & Rottenberg, 2008; Rottenberg, Bylsma, &
Vingerhoets, 2008; Vingerhoets, Cornelius, Van Heck, &
Becht, 2000).
The few articles addressing crying problems in Sjo¨g-
ren’s syndrome documented that some patients with dry
eyes report being able to produce tears after an emotional
event (Van Bijsterveld et al., 2003), whereas other patients
are not able to produce emotional tears, which they con-
sider a serious problem (Kassan, 2001). This suggests that
crying ability differs between individuals and that it is
relevant to mental well-being. However, it is unknown
whether variations in the crying ability of patients with
Sjo¨gren’s syndrome reflect normal variation, whether there
are multiple relevant dimensions of crying, and whether
these dimensions are related to mental well-being. We
expect that patients with Sjo¨gren’s syndrome on average
experience more crying problems than people in the gen-
eral population because of the physical limitation imposed
on crying due to the dry eyes. In the general population
several other aspects of crying have been distinguished
such as crying sensibility, somatic and mental conse-
quences of crying (relief, frustration), and suppression of
crying (Vingerhoets, 2013). A well-known personality
dimension relevant to crying is affect intensity, the strength
with which emotions are experienced (Gross & John, 1997;
Larsen, Diener, & Emmons, 1986). Affect intensity is
reflected in susceptibility to crying in emotional situations,
such as when saying goodbye to a beloved one or when
watching a touching movie (Gross & John, 1997; Larsen
et al., 1986; Vingerhoets, 2013). Our previous study
observed individual differences in affect intensity among
patients with Sjo¨gren’s syndrome, but the level of affect
intensity did not differ between patients and people from
the general population (Van Leeuwen et al., 2012). Another
aspect of crying that may be specific for the Sjo¨gren’s
population involves somatic consequences, such as irrita-
tions in the eyes (Sjo¨gren, 1933), and psychological con-
sequences, such as frustration with crying inability
(Kassan, 2001). Insight into the dimensionality of crying is
important because a possible hampered ability to cry and
adverse consequences of crying in patients with dry eyes
may influence mental well-being and the aforementioned
crying functions of signaling social distress and reducing
arousal.
The aim of this study was to examine whether and which
dimensions of crying can be distinguished in patients with
Sjo¨gren’s syndrome, whether these dimensions are corre-
lated with ocular dryness and mental well-being in patients
with Sjo¨gren’s syndrome, and whether differences in the
scores on these crying dimensions are observed between
patients with Sjo¨gren’s syndrome and a demographically-
matched comparison group from the general population.
We hypothesized that several dimensions of crying prob-
lems are distinguished in patients with Sjo¨gren’s syndrome,
reflecting individual differences in their ability to cry,
susceptibility to crying and the somatic and psychological
consequences of crying. Furthermore, we hypothesized that
patients with Sjo¨gren’s syndrome experience more prob-
lems with crying than people from the general population
and that crying problems are associated with ocular dryness
and lower mental well-being in the Sjo¨gren’s group.
Methods
Participants
Patients with Sjo¨gren’s syndrome (SS) as primary diag-
nosis were included in the study. The criteria of the
American-European Consensus Group on Classification
criteria for Sjo¨gren’s syndrome (Vitali et al., 2002) were
used. These criteria involve the occurrence of ocular and
oral dryness as assessed by clinical interviews and objec-
tive tests of dryness as well as laboratory determinations of
histopathology or serology (Vitali et al., 2002). Patients
with Sjo¨gren’s syndrome were selected from a larger
population of patients with sicca (dryness) symptoms
(N = 937) from the Departments of Rheumatology and
Clinical Immunology of the University Medical Centers
(UMC) in Groningen (n = 270) and Utrecht (n = 667),
The Netherlands. Patients were invited by their rheuma-
tologist to participate in a questionnaire study. From the
937 questionnaires that were sent to patients with sicca
symptoms, 470 completed questionnaires were returned
(50 % response), of which 300 were from patients who
fulfilled the criteria of primary Sjo¨gren’s syndrome.
Respondents (n = 170) were excluded because they did
not have the diagnosis Sjo¨gren’s syndrome (n = 21),
because their diagnosis was non-Sjo¨gren’s sicca syndrome
(n = 115), or because Sjo¨gren’s syndrome was not their
primary diagnosis (n = 34). Patients who did not want to
participate (n = 467) were asked to complete and return a
‘‘non-participation form’’ with questions on demographic
characteristics. As compared to the patients who completed
the questionnaires, the patients who filled out a non-par-
ticipation form (n = 132) had a lower education level
(v2 = 20.19, p\ .001), and were more often single
(v2 = 9.90, p = .04), but did not significantly differ in age,
gender, or ethnicity.
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To acquire a comparison sample, Bachelor’s students
from the department of Clinical and Health Psychology at
Utrecht University were instructed to recruit a sample
comparable to the patient sample with regard to age, gen-
der, and socioeconomic status. This control sample was
recruited in the general population outside the healthcare
setting. Subjects were allowed to have whatever health
problem that may occur in a representative population
sample, except for the diagnosis Sjo¨gren’s syndrome. From
this comparison sample of 179 people, we selected one
control participant to three patients using three consecutive
matching criteria: gender, age, and education level (as a
proxy of socioeconomic status). For example, for each
three women of 60 years old with a low education level,
we selected one control participant with similar charac-
teristics, or as close as possible, starting with gender, then
considering age and then education level. This yielded a
demographically well-matched control sample of 100 par-
ticipants. The control subjects were informed that the study
was about quality of life and fatigue.
All procedures followed were in accordance with the
ethical standards of the responsible committee on human
experimentation (institutional and national) and with the
Helsinki Declaration of 1975, as revised in 2008. Informed
consent was obtained from all participants for being
included in the study.
Measures
Participants filled out a questionnaire including questions
on demographics and medical characteristics (disease
duration, comorbidities and medication use). Hypothy-
roidism, lymphoma and other extraglandular manifesta-
tions as well as diseases not specifically related to
Sjo¨gren’s syndrome were derived from the patient reports
on comorbidities and medication use.
Medication that might influence dryness was catego-
rized into three groups: (1) medication with moistening
side effects given for other reasons than Sjo¨gren’s syn-
drome, e.g., diazepam, (2) medication given for other
reasons than Sjo¨gren’s syndrome increasing dryness or
dehydration, e.g., diuretics and omeprazole, and (3) med-
ication being symptomatic treatment of dry eyes and mouth
to prevent ophthalmological complications or to reduce
problems due to reduced salivary flow and/or dental caries.
Crying
Dimensions of crying were investigated with a newly
developed Sicca Crying Inventory (SCI). Expert discussion
yielded the items using literature on crying and Sjo¨gren’s
syndrome, existing items from crying inventories (Bylsma
et al., 2008; Vingerhoets, 1995; Vingerhoets, Boelhouwer,
Van Tilburg, & Van Heck, 2001), and in-depth interviews
with patients with primary Sjo¨gren’s syndrome. The final
version included 21 items to be answered on a 4-point
Likert scale, with the response options ‘‘1 = seldom or
never,’’ ‘‘2 = sometimes,’’ ‘‘3 = regularly,’’ and
‘‘4 = very often.’’ Items were about crying sensations (one
item); wanting to cry with tears (two items); being able to
cry with tears (five items); situational triggers of crying,
such as watching certain films or saying goodbye to a loved
one (four items); negative somatic consequences of crying,
such as burning eyes or stiffness of the neck (four items);
positive emotional consequences of crying, such as relief
(one item); emotional and behavioral consequences of the
inability to cry, such as acceptance, frustration, and sup-
pression of emotions (four items). SCI items and psycho-
metric properties are presented in Table 2.
Ocular Dryness
The severity during the previous two days of dry eyes and
of a sandy/gravel feeling in the eyes was indicated on
100 mm visual analogue scales between the extremes ‘‘not
troublesome’’ (0 mm) and ‘‘extremely troublesome’’
(100 mm). The mean score on these two scales was used as
measure for ocular dryness.
Mental Well-Being
The mental component summary score (Ware, Kosinski, &
Keller, 1994) of the RAND36-item Health Survey (RAND-
36; VanderZee, Sanderman, Heyink, & De Haes, 1996)
was used to measure mental well-being. This score is a
weighted sum of the eight subscales of this questionnaire.
Two typical items are ‘‘Have you been a very nervous
person?’’ and ‘‘Have you felt downhearted and blue?’’ In
case of missing item scores, the individual respondent’s
mean score on the subscale was taken if missing items did
not constitute more than half of the items. The mental
component summary score has a mean of 50 and standard
deviation of 10 in the general population. A higher score
reflects better mental well-being.
Statistical Analyses
SPSS version 16.0 for Windows was used. A p value\ .05
was considered significant for all test statistics conducted
in the study. Principal axis factoring with oblimin rotation
was used to derive the dimensions of the SCI in the
Sjo¨gren’s group. The number of factors was determined
using the eigenvalue criterion[1, the scree plot of eigen-
values, and the pattern of factor loadings (Field, 2009).
Criteria for excluding an item from the final version of the
SCI were a factor loading \.45 on any single factor
J Clin Psychol Med Settings (2016) 23:77–87 79
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(Comrey & Lee, 1992) or a loading[.32 on two or more
factors (Costello & Osborne, 2005). Scores on the SCI
were computed by averaging the scores on the items
belonging to a dimension. The individual respondent’s
mean score on the scale was taken if missing items did not
constitute more than half of the items. The internal con-
sistency of the final dimensions of the SCI was calculated
using Cronbach’s a coefficients.
Continuous data were screened for deviations from the
normal score distribution. In the Sjo¨gren’s group, the
skewness of the score distributions did not exceed -1.00 or
1.00, meaning that the scores were distributed normally
(e.g., Bulmer, 1979), except for the SCI dimension Sup-
pression (1.57). In the control group, skewness of the score
distributions exceeded 1.00 for the SCI dimensions Somatic
consequences (2.17), Suppression (1.38) and Frustration
(1.20) and for ocular dryness (1.92). To examine differences
between the two groups, we used v2 tests with respect to
frequencies (gender, education level, marital status, work
status, medication use, extraglandular manifestations, and
comorbidities), the Mann–Whitney U-test with respect to
the continuous variable with a non-normal score distribu-
tion in at least one of the two groups (the SCI dimensions
Somatic consequences, Suppression, Frustration and ocular
dryness), and independent samples t-tests for continuous
variables with a normal score distribution in both groups
(age, the SCI dimension Cryability, and mental well-being).
To examine the magnitude of group differences on the
outcome variables, Cohen’s d effect sizes were computed
[(MSjo¨gren - MControls) / SDSjo¨gren]. Effect sizes of 0.20,
0.50, and 0.80 represent small, medium, and large group
differences (Cohen, 1992).
Pearson’s correlation coefficients, adjusted for age,
gender, and medication with moistening or dryness side
effects, were calculated to determine whether the crying
dimensions were correlated with ocular dryness and mental
well-being in the Sjo¨gren’s group. Correlation coefficients




Table 1 shows the demographic and medical characteris-
tics of the patients with Sjo¨gren’s syndrome (n = 300) and
control participants (n = 100). The groups did not signif-
icantly differ in age, gender, education level, marital status,
and comorbidities, but the patients were more often
unemployed than the control participants, more often used
medication for symptomatic treatment of dry eyes and
mouth, and more often had extraglandular manifestations.
For patients, the time since the first appearance of symp-
toms was 14.81 years (SD = 9.22) and the time since
diagnosis was 11.21 years (SD = 8.33).
Sicca Crying Inventory
Factor analysis of the 21 items was performed in the patient
group because the questionnaire was developed to assess
crying problems in this specific group. The factor analysis
yielded a Kaiser–Meyer–Olkin measure of sampling ade-
quacy of 0.89. This indicates that the squared partial cor-
relations between the items are small compared to the
squared correlations between the items and that the factor
analysis yields distinct and reliable factors (Field, 2009).
The Bartlett’s test of sphericity was significant
(v2 = 3635.67, p\ .001), indicating that the null hypoth-
esis that the variables in the correlation matrix are uncor-
related should be rejected (Field, 2009). Therefore, factor
analysis was appropriate.
Table 2 shows the results of the principal axis factoring
for the Sjo¨gren’s group. The scree plot of eigenvalues and
the pattern of factor loadings after rotation suggested four
factors, which were labeled Cryability, Somatic conse-
quences, Frustration, and Suppression. The range of the
item-factor correlations as derived from the structure
matrix, was -.90 to -.64 for Cryability, .68 to .85 for
Somatic consequences, .68 to .79 for Frustration, and .89
and .90 for Suppression.
Four of the 21 items were deleted; one item had only
factor loadings\.45 and three items loaded on more than
one factor[.32. The remaining 17 items loaded clearly on
one of four factors: The first factor including two con-
structs was labeled ‘‘Cryability.’’ The seven items of this
factor reflect the capability to cry with tears (e.g., ‘‘I can
produce tears when crying’’) as well as sensibility to crying
(e.g., ‘‘In sad situations I can cry with tears, e.g., when
saying goodbye to a loved one or when a loved one dies’’).
The other factors were named Somatic consequences (4
items, e.g., ‘‘I experience negative consequences of crying,
such as burning eyes’’), including items indicating the
presence of bodily symptoms after crying, such as a
headache or sore, burning eyes; Frustration (4 items, e.g.,
‘‘There are situations in which I do want to cry, but I
don’t’’), including items assessing the severity of suffering
from the reduced capability to cry; and Suppression (2
items, e.g., ‘‘To avoid negative consequences of crying, I
hold back from crying’’), including items asking how much
tears or emotions are restrained.
The psychometric properties of the final 17-item ques-
tionnaire are shown at the bottom of Table 2. The total
percentage of variance explained by the four factors was
66.0 %. Cronbach’s a coefficients for the four dimensions
were C.78, which is considered good (Bland & Altman,
80 J Clin Psychol Med Settings (2016) 23:77–87
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Table 1 Demographic and
medical characteristics of
patients with Sjo¨gren’s
syndrome (n = 300) and control
participants (n = 100)
Characteristics Sjo¨gren’s syndrome Control participants Comparison p
Age in years, mean (SD) 56.8 (13.6) 56.8 (13.8) t = 0.006 .99
Gender, n (%)
Female 279 (93.0) 91 (91.0) v2 = 0.002 .96
Male 21 (7.0) 7 (7.0)
Unknown 2 (2.0)
Education level, n (%)a v2 = 0.32 .85
Low 73 (24.5) 27 (27.0)
Middle 112 (37.6) 35 (35.0)
High 113 (37.9) 38 (38.0)
Marital status, n (%) v2 = 1.07 .79
Single 22 (7.3) 5 (5.0)
With partner 236 (78.7) 78 (78.0)
Divorced 15 (5.0) 6 (6.0)
Widowed 27 (9.0) 11 (11.0)
Work status, n (%) v2 = 26.54 \.001
Employed C 30 h a week 29 (9.9) 21 (21.0)
Employed\ 30 h a week 77 (26.3) 40 (40.0)
Unemployed 101 (34.5) 11 (11.0)
Retired 79 (27.0) 25 (25.0)
Other 7 (2.4) 3 (3.0)
Medication use, n (%)
With dryness side effects 65 (21.7) 19 (19.0) v2 = 0.32 .57
With moistening side effects 10 (3.3) 1 (1.0) v2 = 1.53 .22
Being symptomatic treatment 109 (36.3) 1 (1.0) v2 = 46.96 \.001
Extraglandular manifestations, n (%) 100 (33.3) 11 (11.0) v2 = 18.66 \.001
Lymphoma 14 (4.7) 0 (0.0)
Muscle and joint complaints 37 (12.3) 7 (7.0)
Neuropathy 12 (4.0) 1 (1.0)
Raynaud phenomenon 12 (4.0) 1 (1.0)
Renal involvement 4 (1.3) 0 (0.0)
SLE/Scleroderma/Dermatomyositis 7 (2.3) 0 (0.0)
Thyroid involvement 21 (7.0) 4 (4.0)
Other glandular symptoms 19 (6.3) 0 (0.0)
Comorbidities, n (%) 130 (43.3) 41 (41.0) v2 = 0.17 .68
Cancer 13 (4.3) 3 (3.0)
Cardiovascular disease 50 (16.7) 21 (21.0)
Osteoporosis 13 (4.3) 3 (3.0)
Diabetes 11 (3.7) 4 (4.0)
Mental problems 27 (9.0) 6 (6.0)
Pulmonary diseases 33 (11.0) 3 (3.0)
Other diseases 37 (12.3) 14 (14.0)
SLE systemic lupus erythematosus
 The significance of the group difference in work status between patients and control participants was
tested without the category ‘‘Other.’’
a Education level: Low primary school or lower vocational secondary education, Middle intermediate
general secondary education or intermediate vocational education, High higher general secondary educa-
tion, higher vocational education, or university education
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1997). Pearson’s correlation coefficients among the four
dimensions varied from -.00 between cryability and sup-
pression to -.42 between cryability and frustration. In the
comparison group, Cronbach’s a coefficients for the four
dimensions were .86, .81, .60, and .78, respectively.
Crying
Figure 1 displays the scores on the SCI dimensions of
patients and control participants. The Cryability items were
answered to occur ‘‘regularly’’ or ‘‘very often’’ by 26 % of
the patients and by 54 % of the control participants.
Somatic consequences were reported ‘‘regularly’’ or ‘‘very
often’’ by 26 % of the patients versus 6 % of the control
participants, Frustration with the reduced capability to cry
by 34 versus 11 %, and Suppression of tears and emotions
by 14 % in both groups.
Table 3 shows the mean or median scores on the four
SCI dimensions. Patients with Sjo¨gren’s syndrome reported
significantly lower Cryability (medium effect size:
d = 0.63) and higher Somatic consequences (medium
effect size: d = 0.69) and Frustration (medium effect size:
Table 2 Factor loadings of the original 21 items of the Sicca Crying
Inventory (Instruction: Indicate for the following statements how
often they occur: ‘Seldom or never’, ‘Sometimes’, ‘Regularly’ or
‘Very often’), and Eigenvalues, percentages of explained variance,
and internal consistency coefficients (Cronbach’s a) of the final items











2. I can produce tears when crying -.79 .03 -.24 .03
4. In unpleasant, negative situations I can cry with tears (e.g. when angry or powerless) -.84 .12 -.13 .01
5. In touching, positive situations I can cry with tears (e.g. when happy) -.87 .03 -.13 -.02
6. In sad situations I can cry with tears (e.g. when saying goodbye to a loved one or when a loved one
dies)
-.86 .02 -.13 .02
7. I can cry with tears when watching some films or listening to certain music -.87 -.02 -.02 -.01
9. I experience positive consequences of crying, such as relief -.65 .17 .06 -.23
16. If I have a ‘crying feeling’, my eyes become wet -.79 -.18 .20 .13
Somatic consequences
8. I experience negative consequences of crying, such as burning eyes .07 .76 .04 .10
12. My eyes are sore after crying .03 .86 .00 -.04
13. My neck or shoulders are stiff after crying -.04 .66 .02 .04
14. I get a headache after crying -.12 .72 -.03 .10
Frustration
3. There are situations in which I do want to cry, but can’t .30 .06 .62 .23
17. If I have a ‘crying feeling’, it feels like I need to cry, but in the end no tears well up .07 .13 .63 .03
19. I would like to be able to cry with tears -.09 -.05 .79 -.08
20. I frustrates me that crying with tears is difficult for me .26 -.05 .73 .11
Suppression
10. To avoid negative consequences of crying, I hold back from crying .03 .24 -.01 .83
11. To avoid negative consequences of crying, I try to suppress my emotions -.03 .08 .04 .88
Deleted items
1. Crying with tears is difficult for me .39 .17 .54 -.10
15. I experience this crying feeling -.42 .06 .69 .01
18. My illness makes it difficult for me to cry .37 -.01 .65 .13
21. I have learnt to live with the fact that crying with tears is difficult for me .31 .10 .44 -.24
Statistics final questionnaire
Eigenvalue 7.23 3.49 1.98 1.16
% explained variance 34.4 16.6 9.4 5.5
Cronbach’s a .93 .78 .80 .85
Items with bold factor loadings were included in the factor
 Items deleted in the final version of the Sicca Crying Inventory because of a too low factor loading or too high cross loadings
82 J Clin Psychol Med Settings (2016) 23:77–87
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d = 0.59) than control participants. The two groups did not
significantly differ in Suppression of tears and emotions
(effect size: d = -0.05). For Cryability, we examined
whether the significant difference was caused by items
reflecting problems with crying ability instead of items
reflecting reduced crying sensibility. This was not the case;
the two groups significantly differed on all items but two:
item 4 reflecting crying ability in unpleasant situations
(p = .08) and item 9 reflecting positive consequences of
crying (p = .11).
Ocular Dryness and Mental Well-Being
Table 3 also presents the median or mean scores on the
measures of ocular dryness and mental well-being. Com-
pared to control participants, patients reported more ocular
dryness (large effect size: d = 1.37) and lower mental
well-being (small effect size: d = 0.46).
Table 4 shows the partial correlation coefficients of time
since first symptoms, time since diagnosis, ocular dryness
and mental well-being with the four dimensions of the SCI,
ocular dryness, and mental well-being in the Sjo¨gren’s
group. Correlations were adjusted for age, gender, and use
of medication with moistening or dryness side effects.
Ocular dryness correlated negatively with Cryability (small
correlation) and positively with Somatic consequences
(small correlation), and Frustration (small correlation) but
not with Suppression. Higher mental well-being was
associated with less Somatic consequences (small correla-
tion), less Frustration (small correlation), and less Sup-
pression (medium correlation), but not with Cryability.
Correlations of time since first symptoms and time since
diagnosis with other variables were not significant.
Discussion
The current study was the first to investigate problems with
crying in patients with Sjo¨gren’s syndrome and relations
with ocular dryness and mental well-being. The Sicca
Fig. 1 Percentages of patients
with Sjo¨gren’s syndrome (right)
and control participants (left)
who reported a low (seldom or
never) to high (very often)
frequency on the four
dimensions of the Sicca Crying
Inventory
Table 3 Measures of central tendency, Means (M) or Medians
(Mdn), and variability, Standard Deviations (SD) or Interquartile
Ranges (Q3 - Q1), on the four dimensions of the Sicca Crying
Inventory (SCI), ocular dryness and mental well-being of patients
with Sjo¨gren’s syndrome (n = 300) and control participants
(n = 100)
Sjo¨gren’s syndrome Control participants Comparison p
SCI dimensions
Cryability M, (SD) 2.00 (0.85) 2.49 (0.70) t = -5.78 \.001
Somatic consequences Mdn,
(Q3 - Q1)
1.75 (2.50 - 1.25) 1.00 (1.50 - 1.00) U = 8127.50 \.001
Frustration Mdn, (Q3 – Q1) 2.00 (2.75 - 1.50) 1.75 (2.00 - 1.25) U = 9703.00 \.001
Suppression Mdn, (Q3 - Q1) 1.00 (2.00 - 1.00) 1.50 (2.00 - 1.00) U = 13936.50 .31
Ocular dryness (mm) Mdn, (Q3 - Q1) 52.00 (75.62 - 27.87) 4.50 (17.00 - 1.00) U = 3846.50 \.001
Mental well-being M, (SD) 44.90 (11.00) 49.51 (9.10) t = -4.15 \.001
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Crying Inventory was developed for this purpose. Four
crying dimensions were identified: Cryability, Somatic
consequences, Frustration, and Suppression.
Cryability
Cryability involves crying sensibility as well as capability
to cry. Crying sensibility appears to reflect a generic per-
sonality dimension reminiscent of affect intensity, the
strength with which emotions are experienced (Gross &
John, 1997; Larsen et al., 1986). The second aspect is the
actual capability of crying, which probably reflects both the
constitutional ability to produce tears as well as the
acquired impediment to produce tears due to Sjo¨gren’s
syndrome. Although patients showed reduced Cryability
(medium effect size), the large overlap between the patient
and control groups on Cryability indicates that this factor
only partly reflects the consequences of Sjo¨gren’s syn-
drome. It was expected that patients with Sjo¨gren’s syn-
drome might have crying problems because of the physical
limitation imposed on crying due to dry eyes, but we did
not expect a deviation from the general population on the
sensibility aspect of crying. However, additional analysis
showed that it was not exclusively crying ability that
caused the difference between patients and the general
population sample; both the items reflecting crying ability
and the items reflecting crying sensibility explained the low
Cryability scores in patients with Sjo¨gren’s syndrome. This
might suggest that lower crying ability not (only) is a
specific consequence of dryness, but (also) a more generic
consequence of having a chronic disease.
Crying has hardly been examined in chronic diseases
(Vingerhoets & Scheirs, 2001). Preliminary research,
involving poorly defined patient groups, indicated that—as
compared to healthy controls—ulcer patients and colitis
patients perhaps cry less frequently and evaluate crying
more negatively than healthy controls (Crepau, 1981).
Another study observed that patients with rheumatoid
arthritis who were able to cry with tears in an emotional
experiment had better disease control than patients who
were not able to cry with tears (Ishii, Nagashima, Tanno,
Nakajima, & Yoshino, 2003). A reduction of crying ability
may be determined by a multitude of factors independent
of ocular dryness that may differ between people with and
without a chronic disease such as emotional (e.g., depres-
sive mood), cognitive and social context variables (Bylsma
et al., 2008; Messmer, 2009; Rottenberg, Bylsma, Wolvin,
& Vingerhoets, 2008; Vingerhoets, Van den Berg, Korte-
kaas, Van Heck, & Croon, 1993; Vingerhoets et al., 2000;
Vingerhoets et al., 2001; Vingerhoets, 2013).
In the present study, the association between Cryability
and ocular dryness was low, and between Cryability and
mental well-being even absent. Whereas we previously
observed that higher affect intensity was associated with
lower mental well-being in patients with Sjo¨gren’s syn-
drome (Van Leeuwen et al., 2012), the current absence of a
correlation between Cryability and mental well-being
indicates that low crying ability and sensibility are not a
serious problem in patients with Sjo¨gren’s syndrome. It
could be hypothesized that the impact of ocular dryness on
the ability to cry depends on the stage of the disease, for
example, that first the production of basal tears stops, then
the reflex tears, and finally the emotional tears (Messmer,
2009). However, we did not find a significant relation
between ocular dryness and time since the first symptoms
and time since diagnosis, despite the heterogeneity of the
patient group on both characteristics. Thus, although
Cryability is a factor that differentiates individuals within
the patient group and groups of patients and controls, there
is no indication that reduced crying ability and sensibility
Table 4 Correlations (r) of time since first symptoms, time since diagnosis, ocular dryness and mental well-being with the four dimensions of
the Sicca Crying Inventory (SCI), ocular dryness and mental well-being in the Sjo¨gren’s group (n = 300)
Time since first symptoms Time since diagnosis Ocular dryness Mental well-being
r (p) r (p) r (p) r (p)
SCI dimensions
Cryability .00 (.99) .01 (.89) -.20 (.001) -.03 (.69)
Somatic consequences .04 (.52) .03 (.66) .27 (\.001) -.17 (.005)
Frustration -.06 (.36) .08 (.22) .18 (.003) -.14 (.03)
Suppression .02 (.79) .03 (.63) .09 (.13) -.36 (\.001)
Ocular dryness (mm) .01 (.90) -.02 (.72) – -.07 (.27)
Mental well-being .11 (.09) -.07 (.25) -.07 (.27) –
All correlations have been adjusted for age, gender and medication use with moistening or dryness side effects
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are of relevance for well-being in patients with Sjo¨gren’s
syndrome.
Overall, the present study demonstrates that ocular
dryness is not a condition sine qua non for crying ability.
Rather, patients with Sjo¨gren’s syndrome are more at risk
of having a reduced ability to cry with tears.
Somatic Consequences
The patient group showed more somatic consequences of
crying than the comparison group (medium effect size).
Somatic consequences of crying showed a medium asso-
ciation with ocular dryness and a small, negative associa-
tion with mental well-being. Adverse somatic
consequences may hamper the reduction of physiological
arousal that is considered a core function of crying when
being distressed (Bylsma et al., 2008; Rottenberg et al.,
2008; Vingerhoets et al., 2000). In the general population,
headaches and facial discomfort are frequently reported
symptoms after crying (Blau, 1995). In a large online study
concerning crying in 35 countries, about 7 % reported
stopping crying to prevent physical effects (Bylsma et al.,
2008). Patients with Sjo¨gren’s syndrome can try to over-
come the adverse somatic consequences of crying by using
tear drops to reduce or prevent burning eyes, or perhaps by
relaxation therapy to prevent or reduce a stiff neck or
shoulders.
Frustration
Patients experienced more frustration because of the
reduced ability to cry than the control participants (medium
effect size). Correlations of frustration with ocular dryness
and reduced mental well-being were small. Patients who
are frustrated about their crying inability may need other
ways to express their feelings and to elicit emotional sup-
port (Hendriks, Croon, & Vingerhoets, 2008; Vingerhoets
et al., 2000). Our previous study showed that processing
and regulating emotions in patients with Sjo¨gren’s syn-
drome generally does not deviate from normal (Van
Leeuwen et al., 2012). This may imply that in some
patients’ frustration due to the reduced ability to cry can be
compensated by intact alternative ways of regulating
emotions, such as expression with words or facial
expression.
Suppression
No differences between the Sjo¨gren’s group and the
comparison group were found with respect to the
suppression of emotions or tears, the fourth SCI dimen-
sion. Patients do not report holding back their tears and
emotions more often than people from the general pop-
ulation. This dimension showed a small negative asso-
ciation with mental well-being. It has been suggested that
patients suffering from other chronic diseases, such as
asthma (Miller, 1987; Miller & Wood, 1997) or migraine
(Evans, 1998), sometimes refrain from crying in order to
prevent an attack, or to prevent further exacerbation. In
general, suppression of emotions has been found to have
negative consequences for affect and well-being (Gross
& John, 2003). With respect to crying, weak connections
between the suppression of crying and mood improve-
ment after crying have been observed (Bylsma et al.,
2008). Suppression of tears has sometimes been thought
to endanger physical health, leading to headaches, ulcers,
hypertension, and insomnia (Cornelius, 1986; Vinger-
hoets, 2013), but empirical evidence in support of this
hypothesis is largely lacking. Although low Cryability,
somatic symptoms after crying, and frustration with
crying are more prevalent among patients with Sjo¨gren’s
syndrome than in the general population, this apparently
does not lead to holding back tears and emotions.
Strengths and Limitations
This was the first study that, inspired by clinical observa-
tions by Henrik Sjo¨gren (1933), examined problems with
crying in patients with Sjo¨gren’s syndrome. The findings of
the current study suggest some relevance of crying prob-
lems for mental well-being. The large sample size of
patients with Sjo¨gren’s syndrome diagnosed by a
rheumatologist and the large sample size of the comparison
group demographically well-matched to the patient group
are major strengths of our study. However, there are also
limitations. First, the descriptive and cross-sectional nature
of the study prevents causal inferences. Second, we did not
have the option to include a comparison group with a
comparable burden of disease but without obstructed tear
production. Third, recruitment of the comparison sample
may have caused an unforeseen selection bias; however,
care was taken that the control group was well-matched to
the patient group with respect to several characteristics.
Fourth, we did not use observations of ocular dryness in
addition to the self-report measures. Finally, we developed
a crying questionnaire because it did not yet exist; the
current study addresses the validity of this questionnaire
preliminarily. Future research should aim at cross-validat-
ing the scales and replicating the group comparison in
another sample.
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Conclusion
Although crying problems are not exclusive for patients
with ocular dryness, but occur in the general population as
well, patients with Sjo¨gren’s syndrome report less crying
sensibility and ability and more somatic consequences and
frustration with crying than people from the general pop-
ulation. These crying problems are associated to a small
extent with more ocular dryness and reduced mental well-
being. Perhaps patients who experience problems with
crying could be helped to rely on other ways of expressing
emotions than crying in tear-inducing situations.
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